Concurrent Indolent Lymphomas in Diffuse Large B-Cell Lymphoma Do Not Worsen Clinical Outcomes
Patients with concurrent diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma were more likely to have germinal center B-cell-like DLBCL.
Sonali Gattani
Editor https://www.cancertherapyadvisor.com
Sonali Gattani is the editor for Hematology Advisor and part of the Medical Communications Group of Haymarket Media. She holds a BA in philosophy-neuroscience-psychology from Washington University in St. Louis, where she served as editor-in-chief of the Washington University Academic Starter Guide.
